Fund Holdings — Versant Venture Management, LLC

Total Portfolio Value:
$151.06M
Total Bought:
$0
Total Sold:
$33.79M
Net Transaction:
-$33.79M
Notable People:
Brian G. Atwood, Samuel D. Colella, Bradley J. Bolzon, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Robin L. Praeger, Robin L. Praeger, Thomas F. Woiwode, Samuel D. Colella, William J. Link, Kirk G. Nielsen, Bradley J. Bolzon, Thomas F. Woiwode, Thomas F. Woiwode, Bradley J. Bolzon, Robin L. Praeger, Kirk G. Nielsen, Thomas F. Woiwode, Versant Ventures Vi Gp-, Versant Venture, Versant Ventures Vii Gp-, Versant Vantage I Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Robin L. Praeger, Thomas F. Woiwode, Clare Ozawa, Clare Ozawa, Thomas F. Woiwode, Robin L. Praeger, Jerel Clayton Davis, Bradley J. Bolzon, Versant Ventures Vi Gp,, Jerel Clayton Davis, Jerel Clayton Davis, Clare Ozawa, Jerel Clayton Davis, Clare Ozawa, Alexander Volker Mayweg, Alexander Volker Mayweg, Versant Vantage Ii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Versant Voyageurs Ii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Ii Gp-, Versant Vantage Iii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Ix Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Iii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Vantage Iii Gp-Gp,, Versant Ventures Ix Gp-, Versant Voyageurs Iii Gp-, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Monte Rosa Therapeutics, Inc.(GLUE)5,652,9224,382,687-1,270,235$41.89M$68.72M45.49%+$26.83M
LENZ Therapeutics, Inc.(LENZ)2,656,8882,656,8880$123.76M$42.51M28.14%-$81.25M
Jade Biosciences, Inc.1,525,8201,525,8200$13.17M$23.54M15.59%+$10.38M
CRISPR Therapeutics AG(CRSP)148,831148,8310$9.65M$7.80M5.17%-$1.84M
Contineum Therapeutics, Inc.(CTNM)542,628542,6280$6.38M$6.20M4.11%-$173.6K
Skye Bioscience, Inc.(SKYE)2,007,7042,007,7040$7.89M$1.51M1.00%-$6.39M
Tempest Therapeutics, Inc.(TPST)269,772269,7720$2.77M$774.2K0.51%-$2.00M
Adverum Biotechnologies, Inc.506,8210-506,821$2.30M$0—-$2.30M
Repare Therapeutics, Inc.2,646,6570-2,646,657$4.66M$0—-$4.66M
Page 1 of 1
Versant Venture Management, LLC — 13F Holdings — Q4 2025 | TickerTrail